Visceral Adiposity Index (Vai) in Type Ii Diabetes Mellitus (Dm) and Its Correlation With Microvascular Complications

Q: What is the clinical evidence from this study?

Study design: Cross-Sectional. Population: Type 2 Diabetes Mellitus (n=250). Intervention: Visceral Adiposity Index vs. Non-diabetic healthy controls. Primary outcome: Visceral adiposity index and presence of microvascular complications.

Q: What does this research mean for the field?

The Visceral Adiposity Index is an effective parameter for assessing the relationship between obesity and type 2 diabetes and correlates with the severity of diabetic microvascular complications. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Vidyashree S. Hulkoti; SOURYA ACHARYA; Kumar Sunil

doi:10.61841/5d0wa509

August 31, 2020International Journal of Psychosocial RehabilitationOpen Access

Visceral Adiposity Index (Vai) in Type Ii Diabetes Mellitus (Dm) and Its Correlation With Microvascular Complications

View Full Paper

Ask AI

Bookmark

Share

Key result

Protocol examines visceral adiposity index link to microvascular complications in planned cross-sectional study.

n=250

Why the study?

An ideal index to quantify the risk and prognosis associated with diabetes and its microvascular complications is crucial for managing obesity-related cardiovascular metabolic disorders.

Does the Visceral Adiposity Index correlate with microvascular complications in patients with type 2 diabetes mellitus compared to healthy controls?

Key Points

To estimate the Visceral Adiposity Index in patients with type 2 diabetes mellitus compared to non-diabetic controls and correlate it with lipid profiles, anthropometric markers, and microvascular complications.
Planned case-control design enrolling 250 participants (125 adults with type 2 diabetes and 125 age- and gender-matched non-diabetic controls) at a tertiary rural teaching hospital in Wardha District.
Calculated Visceral Adiposity Index using body mass index, waist circumference, triglycerides, and high-density lipoprotein cholesterol levels.
Screened microvascular complications via fundoscopy for retinopathy, glomerular filtration rate and urinary albumin for nephropathy, and monofilament and reflex tests for neuropathy.
Visceral Adiposity Index combines standard anthropometric parameters and lipid profiles to serve as an indicator of adipose tissue dysfunction and body fat distribution.
VAI provides a simple and effective metric to evaluate the link between obesity and diabetes and assess the severity of microvascular complications.
Outcome evaluations incorporate weighted analyses to control for key confounders including age, smoking status, and alcoholism.

Study Design

Type

Cross-Sectional (n=250)

Multicenter

No

Structured PICO

Does the Visceral Adiposity Index correlate with microvascular complications in patients with type 2 diabetes mellitus compared to healthy controls?

P

Population

250 adults (125 with type 2 diabetes mellitus and 125 matched healthy controls) planned to be evaluated for visceral adiposity index and microvascular complications.

E

Exposure

Assessment of Visceral Adiposity Index (VAI) using anthropometric data (BMI, waist circumference) and lipid profile (triglycerides, HDL)

C

Comparator

Age and gender-matched non-diabetic healthy controls

O

Outcome

Visceral adiposity index and presence of microvascular complications (diabetic retinopathy, nephropathy, neuropathy)surrogate

Limitations

This is a study protocol and does not report any clinical results.

Implication

This study protocol outlines a plan to evaluate the correlation between the Visceral Adiposity Index and microvascular complications in patients with type 2 diabetes mellitus.

Abstract

Obesity like an iceberg phenomenon is causing a large amount of cardiovascular metabolic disorders, it is crucial to identify an ideal index to quantify the risk and prognosis associated with diabetes. Visceral Adiposity Index along with the simple anthropometric data and lipid profile can be a simple yet effective parameter to evaluate the relationship between obesity and diabetes and can also explain the magnitude of various microvascular complications of diabetes, thus navigating the management of morbidity and mortality associated with it. VAI will help in decreasing the burden of obesity and diabetes mellitus in the society.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hulkoti et al. (2020) conducted a cross-sectional in Type 2 Diabetes Mellitus (n=250). Visceral Adiposity Index vs. Non-diabetic healthy controls was evaluated on Visceral adiposity index and presence of microvascular complications. Visceral Adiposity Index will be evaluated for its correlation with microvascular complications in a planned cross-sectional study of 250 individuals, with no clinical results reported in this protocol.

synapsesocial.com/papers/6ac2fd227180a622ddd4dfb8 https://doi.org/10.61841/5d0wa509

View Full Paper

Ask AI

Bookmark

Share

Visceral Adiposity Index (Vai) in Type Ii Diabetes Mellitus (Dm) and Its Correlation With Microvascular Complications

Key Points

Study Design

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Visceral Adiposity Index (Vai) in Type Ii Diabetes Mellitus (Dm) and Its Correlation With Microvascular Complications

Key Points

Study Design

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading